Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of Exelon Corporation NASDAQ: EXC. In a filing disclosed on August 29th, the Representative disclosed that they had bought between $15,001 and $50,000 in Exelon stock on August 28th.
Representative Marjorie Taylor Greene also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of Southern NYSE: SO on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of Morgan Stanley NYSE: MS on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of Novo Nordisk A/S NYSE: NVO on 8/28/2025.
- Purchased $15,001 - $50,000 in shares of Ryman Hospitality Properties NYSE: RHP on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOG on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of MercadoLibre NASDAQ: MELI on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of United Parcel Service NYSE: UPS on 8/28/2025.
Exelon Stock Up 0.0%
NASDAQ:EXC traded up $0.01 during trading hours on Wednesday, hitting $43.38. 7,903,245 shares of the company's stock traded hands, compared to its average volume of 5,419,909. The firm has a market cap of $43.81 billion, a P/E ratio of 16.49, a P/E/G ratio of 2.56 and a beta of 0.41. The stock's fifty day moving average price is $43.97 and its two-hundred day moving average price is $44.20. Exelon Corporation has a twelve month low of $35.94 and a twelve month high of $48.11. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.85 and a current ratio of 0.95.
Exelon (NASDAQ:EXC - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $0.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.02. Exelon had a return on equity of 9.85% and a net margin of 11.16%.The firm had revenue of $5.43 billion during the quarter, compared to analysts' expectations of $5.47 billion. During the same quarter in the prior year, the business earned $0.47 earnings per share. The company's revenue was up 1.2% on a year-over-year basis. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. On average, research analysts expect that Exelon Corporation will post 2.64 earnings per share for the current fiscal year.
Exelon Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Monday, August 11th will be issued a dividend of $0.40 per share. The ex-dividend date is Monday, August 11th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.7%. Exelon's payout ratio is currently 60.84%.
Institutional Trading of Exelon
Institutional investors and hedge funds have recently bought and sold shares of the company. Centaurus Financial Inc. purchased a new position in Exelon in the 2nd quarter worth $201,000. Orion Porfolio Solutions LLC increased its position in Exelon by 37.8% in the second quarter. Orion Porfolio Solutions LLC now owns 25,952 shares of the company's stock worth $1,127,000 after buying an additional 7,119 shares in the last quarter. Thrivent Financial for Lutherans lifted its holdings in Exelon by 61.7% in the 2nd quarter. Thrivent Financial for Lutherans now owns 66,707 shares of the company's stock worth $2,894,000 after purchasing an additional 25,458 shares in the last quarter. MASTERINVEST Kapitalanlage GmbH purchased a new stake in Exelon during the second quarter valued at $825,000. Finally, Stance Capital LLC bought a new position in Exelon during the 2nd quarter valued at about $1,843,000. 80.92% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research firms have weighed in on EXC. Morgan Stanley reissued an "outperform" rating on shares of Exelon in a research note on Thursday, August 21st. KeyCorp cut their target price on shares of Exelon from $39.00 to $37.00 and set an "underweight" rating for the company in a research note on Wednesday, July 16th. Finally, UBS Group reiterated a "neutral" rating and issued a $48.00 price target (up from $47.00) on shares of Exelon in a research note on Friday, July 11th. Five research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $47.20.
Get Our Latest Report on Exelon
About Representative Greene
Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia's 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.
Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia's 14th Congressional District. She declared candidacy for the 2026 election.
About Exelon
(
Get Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.